Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care for neurodegenerative disease, prostate cancer, and metastatic liver tumors. An agreement signed by both organizations will also expand access to new imaging and interventional technologies.

“Improving the diagnosis and treatment of neurodegenerative disease and cancer is core to our purpose as a company,” stated John Kowal, president and head of the Americas at Siemens Healthineers. “Our collaboration with Mayo Clinic creates significant opportunities to help extend the quantity and quality of patients’ lives.”

Initial areas for collaboration include:

• Neurodegenerative disease: Developing and bringing to clinical use artificial intelligence (AI)-enabled MRI protocols for improved diagnostic accuracy and patient monitoring.
• Surgical care pathway innovation: Applying digital twin technologies to re-imagine how patients experience surgery, enhancing their care and improving operational efficiency.
• Prostate cancer: Jointly investigating the role of AI in minimizing biopsies and ways to integrate minimally invasive, advanced imaging into diagnostic and therapeutic procedures.
• Minimally invasive, image-guided interventional suites: Creating spaces to use the latest image-guided technologies for the precise detection and treatment of liver metastases.
• Ultra-high-field MRI innovation center: Using ultra-high-field MRI protocols, taking advantage of the technology’s high resolution and enhanced contrast, for diagnostic and surgical planning in patients with complex neurological diseases.
• Whole Body PET/CT & PET/MR innovation center: Using whole-body PET/CT emphasizing theranostics treatment for certain cancers, with simultaneous anatomical and metabolic MR imaging, to enable precise diagnostic and therapeutic planning.

“Our goal is to make care more precise, less invasive and more responsive to each patient’s needs,” said Eric Williamson, M.D., professor and chair, Diagnostic Radiology, Mayo Clinic. “By expanding our collaboration, we can bring advanced imaging, artificial intelligence, and innovative treatment approaches directly into everyday clinical care, potentially helping patients receive earlier diagnoses, more personalized treatment plans and better outcomes.”

Siemens Healthineers is a global provider of healthcare equipment, solutions, and services, with activities in more than 180 countries and direct representation in over 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a medical technology company, Siemens Healthineers is principally active in imaging, diagnostics, cancer care, and minimally invasive therapies, augmented by digital technology and artificial intelligence.

Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education ,and research, and providing compassion, expertise ,and answers to those needing healing.